Early tumor shrinkage and depth of response as predictors of favorable treatment outcomes in patients with metastatic colorectal cancer treated with FOLFOX/FOLFIRI plus cetuximab.

Authors

S.P. Somashekhar

S.P. Somashekhar

Manipal Comprehensive Cancer Center, Bangalore, India

S.P. Somashekhar , Amit Rauthan , Ashwin K Rajgopal , Rohit Kumar C

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 631)

DOI

10.1200/JCO.2019.37.4_suppl.631

Abstract #

631

Poster Bd #

K16

Abstract Disclosures